Loading
Latest filing published 01 Mar 2017 for WaferGen Bio-systems, Inc., €347k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Rolland Carlson in WaferGen Bio-systems, Inc. In total, 3 filings cover trades dated from 12 May 2015 to 28 February 2017.
The open-market record is one-sided, with 1 purchase and not one sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.
The record was last updated on 1 March 2017 with a transaction (€347k) in WaferGen Bio-systems, Inc. The most recent open-market purchase was published on 21 October 2015, 4,021 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations